Founding Director, Forte Medical
Peezy Midstream clinical evidence shows as low a 0% contamination in Primary Care settings and a 70% reduction of false-positive dipped urine specimens in antenatal settings leading to safer screening, more prompt diagnoses, reduced antibiotic prescribing. With up to 66% saving on lab spend proven in GP surgeries, the NHS Primary Care providers stand to benefit from significant cost and efficiency savings too.
The company is developing new devices to work with novel early stage cancer tests, sports dope testing and more.
22 June 2021
WATCH ON DEMAND